FCM
DPLO

Frontier Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Frontier Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-392,928
Closed -$1.93M – 304
2019
Q3 		$1.93M Sell
392,928
-379,206
-49% -$2.12M 0.02% 272
2019
Q2 		$4.7M Sell
772,134
-320,046
-29% -$1.7M 0.04% 263
2019
Q1 		$6.35M Sell
1,092,180
-73,847
-6% -$763K 0.05% 255
2018
Q4 		$15.7M Sell
1,166,027
-2,369,190
-67% -$39.9M 0.13% 196
2018
Q3 		$68.6M Buy
3,535,217
+1,614,645
+84% +$34.4M 0.44% 84
2018
Q2 		$49.1M Sell
1,920,572
-1,998,479
-51% -$46.6M 0.35% 112
2018
Q1 		$79M Buy
3,919,051
+94,861
+2% +$2.21M 0.57% 58
2017
Q4 		$76.8M Sell
3,824,190
-213,023
-5% -$4.19M 0.56% 62
2017
Q3 		$83.6M Sell
4,037,213
-1,640,017
-29% -$27.7M 0.6% 52
2017
Q2 		$84M Buy
5,677,230
+221,769
+4% +$3.7M 0.61% 51
2017
Q1 		$87M Buy
+5,455,461
New +$78.7M 0.64% 42

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Frontier Capital Management's DPLO Position: Q4 2019 in Review

Frontier Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 392,928 shares — an estimated $1.93M sold.

Frontier Capital Management first reported a position in DPLO in Q1 2017 and held it in 11 quarters. The position peaked at $87M in Q1 2017. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Frontier Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Frontier Capital Management sold 392,928 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $1.93M.
  • Frontier Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2017 and held it in 11 quarters.
  • Frontier Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $87M in Q1 2017.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Frontier Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.